Drug Type CAR-NK |
Synonyms Cord Blood-Derived CAR-NK Cells Targeting Claudin18.2(Hangzhou RonGu Biotechnology Limited Company), Cord Blood-Derived CAR-NK Cells(Hangzhou RonGu Biotechnology Limited Company) |
Target |
Mechanism CLDN18.2 modulators(Claudin 18.2 modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced gastric carcinoma | Phase 1 | CN | 13 Jun 2024 | |
Advanced gastric carcinoma | Phase 1 | CN | 13 Jun 2024 | |
Advanced Pancreatic Adenocarcinoma | Phase 1 | CN | 13 Jun 2024 | |
Advanced Pancreatic Adenocarcinoma | Phase 1 | CN | 13 Jun 2024 | |
Pancreatic Adenoma | Phase 1 | CN | 13 Jun 2024 | |
Pancreatic Adenoma | Phase 1 | CN | 13 Jun 2024 |